CD52 and Alzheimer disease: PBMCs from 28 patients with AD, 21 patients with CD, and 17 HCs underwent phenotypic evaluation for CD52 expression in CD4+ T cell, CD8+ T cell and CD4+CD25+CD127- Treg populations, flow cytometry gating strategies are described in Fig. 1a.